The role of the new oral anticoagulants in the treatment of coronary disease

• Hernando del Portillo,
• Juan J. Badimón,
• Jaime R. Cabrales,
• Darío Echeverri

Affiliations

Hernando del Portillo

Department of Hemodynamics and Cardiovascular Interventionism, Fundación CardioInfantil – Instituto de Cardiología – Department of Medicine, Universidad del Rosario, Bogotá, Colombia

Juan J. Badimón

Atherothrombosis Research Unit, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, United States

Jaime R. Cabrales

Department of Hemodynamics and Cardiovascular Interventionism, Fundación CardioInfantil – Instituto de Cardiología – Department of Medicine, Universidad del Rosario, Bogotá, Colombia

Darío Echeverri

Department of Hemodynamics and Cardiovascular Interventionism, Fundación CardioInfantil – Instituto de Cardiología – Department of Medicine, Universidad del Rosario, Bogotá, Colombia